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Abstract The distribution of extracellular-superoxide dismu-
tase (EC-SOD) levels in healthy Australian subjects was
consistent with two distinct phenotypes in which the smaller
group of subjects (3.3%) had 15-fold higher levels. The EC-SOD
levels in individuals homozygous for endothelial constitutive
nitric oxide synthase 4a (ecNOS4a), a rare allele for ecNOS
repeat polymorphism at intron 4, were significantly lower than
those in ecNOS4A/a and ecNOS4A/A subjects. Furthermore,
NO levels were negatively correlated with the EC-SOD levels in
common EC-SOD phenotype subjects. Whilst the mechanism
remains speculative, it is possible that there is a significant
interaction between EC-SOD and ecNOS, or that common
factor(s), either genetic or environmental, influence both of them.
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1. Introduction
The occurrence of highly reactive oxygen species and their
destruction by anti-oxidants is in equilibrium in healthy mam-
malian organisms. Disturbance of this homeostasis can cause
numerous disorders. It has been suggested that free radicals
are involved in various cardiovascular diseases including athe-
rosclerosis. Thus, the defense systems against active oxygen
species are critical for protecting blood vessel walls against
oxidative damage.
Nitric oxide (NO) is produced by a variety of cells in the
vascular system, including endothelial cells, macrophages,
smooth muscle cells, platelets and ¢broblasts. Three NO syn-
thases (NOSs), neuronal constitutive NOS (ncNOS or NOS1),
inducible NOS (iNOS or NOS2) and endothelial constitutive
NOS (ecNOS or NOS3), are responsible for NO biosynthesis
in these cells [1]. NO is produced constitutively and contrib-
utes to the modulation of vasomotor tone and to inhibition of
platelet and leukocyte aggregation and adhesion to endothe-
lium, properties that have been shown to be anti-atherogenic
[2]. While iNOS is not normally expressed, it can be induced
by cytokines and lipopolysaccharides in some pathological
processes, such as circulatory shock and in£ammation [3].
NO reacts extremely rapidly with superoxide to produce
peroxynitrite, a potential mediator of oxidant-induced cellular
injury, at or near the di¡usion-limited rate (4.3^6.7U109 M31
s31). Peroxynitrite is a potent oxidant, capable of oxidizing
thiols [4,5] and DNA bases [6], and of causing tyrosine nitra-
tion [7] and initiating lipid peroxidation [8]. Superoxide dis-
mutase (SOD) is a potent scavenger of superoxide at the rate
of 2U109 M31 s31. NO may compete with SOD for super-
oxide, thereby removing superoxide and thus supporting its
antioxidant role [9]. Extracellular-SOD (EC-SOD or SOD3) is
the principal enzymatic scavenger of superoxide in the extra-
cellular space [10]. In the vasculature, EC-SOD is in equilib-
rium between the plasma phase and heparan sulfate proteo-
glycans in the glycocalyx of the endothelium [11]. Molecular
genetic studies of EC-SOD have shown that a single base
substitution causing substitution of glycine for arginine-213
(R213G) in the heparin-binding domain of this enzyme causes
the extremely high plasma level of EC-SOD [12^15]. The high
plasma EC-SOD phenotype was found in a small proportion
of healthy subjects, 6% in Japanese [12], and 2% in Swedish
[14]. It is unclear whether this phenotype exerts bene¢cial or
deleterious e¡ects on individuals.
The endothelium is a primary target of vascular injury.
Elevation of NO and/or depression of SOD in endothelium
or its microenvironment might cause the pathogenesis of vas-
cular disorders. The hypothesis of interactions between NO
and SOD is supported by the ¢nding that expressions of EC-
SOD and iNOS were elevated simultaneously in human and
rabbit atherosclerotic lesions [16]. We have reported a genetic
contribution of ecNOS to plasma NO levels, as indicated by
levels of plasma nitrite and nitrate (NOx), and an association
of the rare allele of a 27-bp repeat in intron 4 with a tobacco
smoking-dependent increased risk of coronary artery diseases
(CAD) [17,18]. The balance of these two systems would
clearly be important in many pathological processes such as
atherogenesis. In the present study, we explored associations
between ecNOS polymorphism and EC-SOD levels in an Aus-
tralian Caucasian population.
2. Materials and methods
2.1. Nuclear families in the study
We collected blood samples from 242 members of 57 nuclear fam-
ilies. These families were healthy volunteers recruited from our Heart
Health Education Program for family-based primary coronary pre-
vention. They were selected for the current study on the basis that
all were of white European origin and residing in Sydney, and none
were current smokers. They were advised to remain on their usual diet
before the blood collection and all were healthy at the time of study.
Written consent was obtained from every child’s parent for this study.
The study was approved by the Ethics Committee of the University of
New South Wales. A 4-ml venous blood sample was drawn into an
EDTA-containing sample tube after an overnight fast (12^14 h). The
blood sample was centrifuged within 2 h and plasma was stored at
370‡C in aliquots until analysis. DNA was extracted from the frozen
cellular blood component by a salting-out method [17]. The extracted
DNA was stored at 4‡C until analysis.
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2.2. Assay of EC-SOD
The EC-SOD concentration was determined by the enzyme-linked
immunosorbent assay (ELISA) as described previously [19].
2.3. Genotyping of the 27-bp polymorphism in intron 4 of the ecNOS
gene
A polymerase chain reaction (PCR) method was used for the gen-
otyping of the repeat polymorphism as described previously [18]. We
used oligonucleotide primers that £ank the region of the 27-bp repeat
in intron 4 of the ecNOS gene. The PCR products were electropho-
resed on 8% polyacrylamide gels and visualized by silver staining.
There are two alleles di¡ering by one repeat, i.e. di¡ering by 27 bp
in size. We have denoted these two alleles as ecNOS4a for the rare
four repeat allele and ecNOS4A is the common allele.
2.4. Determination of plasma NOx levels
Since NO is unstable and quickly oxidized to nitrate and nitrite
after production, to estimate plasma NO levels, circulating NOx
was determined using a modi¢cation of the method described by
Wang et al. [20]. Nitrate was measured as nitrite after enzymatic
conversion by nitrate reductase, and nitrite was measured after de-
proteinization using the Griess color reaction, which was read at a
wavelength of 540 nm. Values obtained by this procedure represent
the sum of nitrite and nitrate derived from NO.
2.5. Statistical analyses
The levels of SODs and NOx measured are presented as
means þ S.D., and di¡erences among subgroups were compared by
the Kruskal-Wallis test for three subgroups (ecNOS4A/A, ecNO-
S4A/a and ecNOS4a/a), or by Student’s t-test for two groups (low
EC-SOD and high EC-SOD). A general factorial design of ANOVA
and a linear regression model were used to assess and control for the
confounding factors.
3. Results
Two hundred and forty-two individuals were included in
the current study. Serum EC-SOD levels ranged from 29.9
to 1798 Wg/l and were distributed in two discrete groups of
low-level (29.9^152.1 Wg/l, n = 234) and high-level (940.2^1798
Wg/l, n = 8, frequency 3.3% of tested samples). All of the tested
high-level EC-SOD individuals were found to carry the
R213G mutation, whereas none of the low-level EC-SOD
subjects had this mutation.
The frequency distribution of the ecNOS4 genotypes was
0.690 (n = 167) for ecNOS4A/A, 0.285 (n = 69) for ecNOS4A/a
and 0.025 (n = 6) for ecNOS4a/a. The ecNOS4a/a homozy-
gotes exhibited two-fold higher levels of the circulating plasma
NOx than the other subjects (Table 1). Age and sex distribu-
tions of the two groups of EC-SOD level and the three groups
of ecNOS4 genotype were not signi¢cantly di¡erent.
Table 1 shows that EC-SOD levels of ecNOS4a/a subjects
were signi¢cantly lower than those of the ecNOS4A/A and
ecNOS4A/a groups. When subgroups of common (low level)
and mutant (high level) EC-SOD phenotypes were considered
separately, there were no ecNOS4a/a individuals with the mu-
tant EC-SOD phenotype. To con¢ne the comparison to indi-
viduals of the common phenotype, EC-SOD levels in ecNO-
S4a/a subjects were still signi¢cantly lower than those in
ecNOS4A/A subjects and tended to be lower than those in
ecNOS4A/a subjects (Table 1). Furthermore, levels of NOx
were negatively and signi¢cantly correlated with the levels of
EC-SOD (L=30.196, r = 0.181, F = 7.799, P = 0.006) in the
subgroup of common phenotype individuals. In a general fac-
torial design of ANOVA, the ecNOS4 polymorphism re-
mained a signi¢cant contributor to EC-SOD levels (F = 4.57,
P = 0.011) after controlling for age (F = 77.84, P = 0.0001) and
sex (F = 5.21, P = 0.023). The adjusted means þ S.E.M. of EC-
SOD for ecNOS4A/A, A/a and a/a were 80.9 þ 1.7 Wg/l,
78.9 þ 2.6 Wg/l and 54.1 þ 8.8 Wg/l respectively.
Whilst none of the subjects in the high EC-SOD group were
ecNOS4a/a homozygotes, the frequency of the homozygotes
in the common subgroup was 2.56%. The plasma NOx levels
were not di¡erent in the two groups (Table 2).
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Table 1
Relation between the ecNOS polymorphism and EC-SOD level
ecNOS4A/A ecNOS4A/a ecNOS4a/a P-value
Total
Sample number 167 69 6
Age 24.7 þ 16.2 25.9 þ 15.7 23.2 þ 14.2 0.7360
Male/female 91/76 38/32 5/1
NOx (Wmol/l) 33.7 þ 17.0 36.6 þ 28.4 74.9 þ 56.3 0.0834
EC-SOD (Wg/l) 135.4 þ 264.1 91.1 þ 106.6 57.8 þ 20.7b;c 0.0202
Common EC-SOD (Wg/l)a 81.4 þ 25.2 78.6 þ 24.6 57.8 þ 20.7b 0.0317
Number of subjects without rare EC-SOD allele 160 68 6
Number of subjects with rare EC-SOD allele 7 1 0
Males
Sample number 91 38 5
EC-SOD (Wg/l) 147.9 þ 277.2 86.6 þ 26.2b 59.1 þ 22.9b 0.0688
Common EC-SOD (Wg/l)a 82.2 þ 25.8 86.6 þ 26.2 59.1 þ 22.9 0.0611
Number of subjects without rare EC-SOD allele 86 38 5
Number of subjects with rare EC-SOD allele 5 0 0
Females
Sample number 76 32 1
EC-SOD (Wg/l) 120.5 þ 248.5 96.5 þ 157.6 51.1 0.0446
Common EC-SOD (Wg/l)a 80.5 þ 24.5 68.4 þ 18.2b 51.1 0.0336
Number of subjects without rare EC-SOD allele 74 31 1
Number of subjects without common EC-SOD allele 2 1 0
aEC-SOD levels in the subgroup without rare EC-SOD allele and their plasma EC-SOD level distributed below 150 Wg/l.
bP6 0.05 vs. ecNOS4A/A group.
cP6 0.05 vs. ecNOS4A/a group by Student’s t-test.
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4. Discussion
We reported previously that the frequency of ecNOS4a/a
homozygotes in the CAD population was six times higher
than that in the healthy population [17], which suggested
the contribution of ecNOS to the development of CAD. We
further indicated the signi¢cant genetic contribution of ecNOS
to plasma NOx levels by showing that NOx levels in ecNO-
S4a/a individuals were twice as high as levels in individuals
with the ecNOS4A allele [18]. Despite many environmental
factors that alter the plasma NO level, approximately 30%
of the variance in NO level is due to the ecNOS4 polymor-
phism [18]. The present study identi¢ed a signi¢cant associa-
tion between ecNOS polymorphism and EC-SOD phenotype.
Whilst the mechanism remains speculative, it is possible that
these two factors interact in vivo, or that common factor(s),
either genetic or environmental, may in£uence both ecNOS
and EC-SOD.
Serum EC-SOD levels in subjects carrying the R213G mu-
tation were about 15-fold higher than in subjects without the
mutation. However, the mutant EC-SOD has the same enzy-
matic speci¢c activity as the common phenotype enzyme [14].
The present results showed a signi¢cantly inverse correlation
between circulating NOx levels and EC-SOD levels in the
subgroup of common (low) EC-SOD phenotype, although
the EC-SOD mutation did not in£uence the plasma NOx
levels (Table 2). Whilst continuous release of NO by the en-
dothelium into the circulation has important biological func-
tions relevant to the prevention of atherogenesis, high circu-
lating NO levels are toxic. This toxic e¡ect is thought to be at
least partly mediated by active end metabolites of NO, which
may initiate lipid peroxidation in low-density lipoprotein
[21,22]. It can be speculated that these oxidative metabolites
may always be produced and toxic even when the NO levels
are within physiological range, and this e¡ect may be attenu-
ated by constant EC-SOD production. It is possible that a
high level of EC-SOD in plasma quickly dismutates the super-
oxide produced by stimulated neutrophils and prevents the
production of toxic peroxynitrite in the circulation. Above
¢ndings are consistent with the fact that the ecNOS4a homo-
zygotes, whose plasma NOx level is two-fold higher and EC-
SOD level is signi¢cantly lower than those of individuals with
the ecNOS4A allele, are predisposed to coronary injury. Addi-
tional oxidant stress such as cigarette smoking will raise the
risk further.
In summary, our study demonstrated a highly signi¢cant
association between plasma EC-SOD and the ecNOS4 poly-
morphism, in which low EC-SOD levels were related to the
rare ecNOS4a allele, which was also associated with high NOx
levels. We further showed a signi¢cant negative correlation
between the plasma NOx and EC-SOD levels in subjects
with common (low-level) EC-SOD phenotypes. Whilst further
studies are needed to explore the mechanisms, these ¢ndings
suggest that NO and EC-SOD may function conjointly in
physiology and pathology.
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Table 2
Relation between the EC-SOD phenotypes, ecNOS polymorphism, and other factors
Low EC-SOD High EC-SOD P-value
Sample number n = 234 n = 8
Age 25.2 þ 16.0 19.9 þ 16.2 0.3917
Male/female 129/105 5/3
EC-SOD (Wg/l) 80.0 þ 25.1 1317 þ 262.9 6 0.0001
NOx (Wmol/l) 35.7 þ 23.4 33.6 þ 16.0 0.7392
Frequency of ecNOS4a/a (%) 2.56% 0%
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